Patients with hypertrophic cardiomyopathy frequently die suddenly and unexpectedly, presumably from cardiac arrhythmias.' 3 In a recent Icelandic study the inheritance pattern of hypertrophic cardiomyopathy was described.4 The diagnosis was based on inordinate interventricular septal thickening (1l3 cm). Most of the patients had no symptoms, and were only identified after necropsy findings suggesting hypertrophic cardiomyopathy in a close relative. No single echocardiographic marker, however, is pathognomic for hypertrophic cardiomyopathy.5-7 It has been suggested that an interventricular septal thickness cut-off point at 1*3 cm may be both too sensitive and non-specific as a diagnostic criterion.8-10
Patients with hypertrophic cardiomyopathy frequently die suddenly and unexpectedly, presumably from cardiac arrhythmias.' 3 In a recent Icelandic study the inheritance pattern of hypertrophic cardiomyopathy was described. 4 The diagnosis was based on inordinate interventricular septal thickening (1l3 cm). Most of the patients had no symptoms, and were only identified after necropsy findings suggesting hypertrophic cardiomyopathy in a close relative. No single echocardiographic marker, however, is pathognomic for hypertrophic cardiomyopathy.5-7 It has been suggested that an interventricular septal thickness cut-off point at 1*3 cm may be both too sensitive and non-specific as a diagnostic criterion. [8] [9] [10] To study the validity of this echocardiographic criterion we have compared the prevalence and types of cardiac arrhythmias in the group of relatives who had an interventricular septal thickn&ss of 1-3 cm or more in relation to those relatives whose septum was thinner than 1-3 cm.
Patients and methods
Our previous study included 58 close relatives of eight Accepted for publication 25 May 1982 198 patients (out of a total of 11) who had necropsy criteria of hypertrophic cardiomyopathy in Iceland during the years 1966 to 1977. 4 The eight index patients were male patients and all died suddenly from cardiac causes except one who died in an accident. 1' Their average age at the time of death was 29 years (3 months to 47 years) and only two had had symptoms previously.
Twenty-three relatives had echocardiographic criteria (>1-3 cm) of hypertrophic cardiomyopathy. Of these, 22 were investigated by 24 In all three groups, ambulatory 24 hour electrocardiographic recordings were performed, using onechannel Oxford Medilog recorders. All subjects were instructed to record their activities and complaints at least hourly during waking hours. A Reynolds High Speed Pathfinder machine was used for arrhythmia analysis. The same physician (IB) analysed and classified all the recordings. Ventricular arrhythmias were classified according to Ryan et al. 16 (Table 2) . Unless otherwise stated, Fisher's exact test for 2x2 tables was used to assess statistical significance.
Results Fig. 1 shows the total number of supraventricular extrasystoles during 24 hours in patients with hypertrophic cardiomyopathy, in their relatives, and in the control group. Seven patients with hypertrophic car- Fig. 5 shows the relation between the ventricular arrhythmia classification and the total number of ventricular extrasystoles during 24 hours. Twelve (55%) patients with hypertrophic cardiomyopathy had more than 10 ventricular extrasystoles in 24 hours but only four (10%) out of the control group and two (7P/o) in the group of relatives. The cardiomyopathy group differed significantly from the others in this respect (p<0.00l) while there was no difference between normal relatives and control subjects. The number of subjects with 100 or more ventricular extrasystoles every 24 hours, however, did not differ significantly between the groups. All the most serious ventricular arrhythmias occurred during waking hours. Four patients complained of dizziness and palpitation during the recording. The timing of such complaints, however, did not coincide with the occurrence of serious arrhythmias.
Discussion
This study showed a high incidence of cardiac arrhythmias among symptom-free patients or those with mild symptoms with a thick ventricular septum and close familial links with deceased patients with hypertrophic cardiomyopathy compared with their normal relatives and a normal group. The arrhythmias were always unexpected and not felt by the patients, even in three people with ventricular tachycardia. The common occurrence of arrhythmias in this group supports our previous contention that most of them do indeed suffer from cardiomyopathy.4 19 had no symptoms and two thirds had symptoms consistent with hypertrophic cardiomyopathy. They found little difference in arrhythmias between the two groups and, on the whole, the four studies show an interesting conformity, though the selection of patients varied. Our results support those of Savageet al. 19 who found that the correlation between symptoms and cardiac arrhythmias in hypertrophic cardiomyopathy is poor.
The annual attrition rate in hypertrophic cardiomyopathy is 3 to 4%.220 Maron et 25 and Bouhour et al. 26 It therefore seems justifiable to hope that vigorous antiarrhythmic treatment under these circumstances may prevent sudden death in some cases. Recent trials using amiodarone appear particularly promising. 27 The results of this study also suggest that relatives of patients with hypertrophic cardiomyopathy should be investigated with echocardiograms and then ambulatory 24 hour electrocardiographic recording, if there is a thickened interventricular septum. Finally, our study shows that many patients with hypertrophic cardiomyopathy will remain undiagnosed unless effective objective screening methods are applied to individuals judged to be particularly at risk.
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